Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Acute azotaemia without serum cystatin C elevation.

Saka Y, Kato A, Tawada N, Noda Y, Niwa S, Mimura T, Naruse T, Watanabe Y.

Nephrology (Carlton). 2019 Jul;24(7):775. doi: 10.1111/nep.13540. Epub 2019 Apr 29. No abstract available.

PMID:
31037788
2.

Thiamine status in end-stage chronic kidney disease patients: a single-center study.

Saka Y, Naruse T, Kato A, Tawada N, Noda Y, Mimura T, Watanabe Y.

Int Urol Nephrol. 2018 Oct;50(10):1913-1918. doi: 10.1007/s11255-018-1974-y. Epub 2018 Sep 4.

PMID:
30182293
3.

Successful rituximab treatment of TAFRO syndrome with pathological findings of glomerular endothelial damage.

Noda Y, Saka Y, Kato A, Mimura T, Naruse T.

Clin Nephrol Case Stud. 2018 Jun 22;6:16-20. doi: 10.5414/CNCS109400. eCollection 2018.

4.

Evaluation of Treatment Coverage and Enhanced Mass Drug Administration for Onchocerciasis and Lymphatic Filariasis in Five Local Government Areas Treating Twice Per Year in Edo State, Nigeria.

Griswold E, Eigege A, Ityonzughul C, Emukah E, Miri ES, Anagbogu I, Saka YA, Kadiri S, Adelamo S, Ugbadamu P, Ikogho C, Richards FO.

Am J Trop Med Hyg. 2018 Aug;99(2):396-403. doi: 10.4269/ajtmh.17-1004. Epub 2018 Jun 21.

5.

Integrated risk mapping and landscape characterisation of lymphatic filariasis and loiasis in South West Nigeria.

Brant TA, Okorie PN, Ogunmola O, Ojeyode NB, Fatunade SB, Davies E, Saka Y, Stanton MC, Molyneux DH, Russell Stothard J, Kelly-Hope LA.

Parasite Epidemiol Control. 2017 Dec 28;3(1):21-35. doi: 10.1016/j.parepi.2017.12.001. eCollection 2018 Feb.

6.

In Southern Nigeria Loa loa Blood Microfilaria Density is Very Low Even in Areas with High Prevalence of Loiasis: Results of a Survey Using the New LoaScope Technology.

Emukah E, Rakers LJ, Kahansim B, Miri ES, Nwoke BEB, Griswold E, Saka Y, Anagbogu I, Davies E, Ityonzughul C, D'Ambrosio M, Bakalar M, Fletcher DA, Nutman T, Kamgno J, Richards FO.

Am J Trop Med Hyg. 2018 Jul;99(1):116-123. doi: 10.4269/ajtmh.18-0163. Epub 2018 May 10.

7.

Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.

Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Yoshio T, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.

Clin Exp Nephrol. 2018 Dec;22(6):1266-1280. doi: 10.1007/s10157-018-1579-x. Epub 2018 Apr 20.

PMID:
29679356
8.

Renoprotective effects of topiroxostat for Hyperuricaemic patients with overt diabetic nephropathy study (ETUDE study): A prospective, randomized, multicentre clinical trial.

Mizukoshi T, Kato S, Ando M, Sobajima H, Ohashi N, Naruse T, Saka Y, Shimizu H, Nagata T, Maruyama S.

Nephrology (Carlton). 2018 Nov;23(11):1023-1030. doi: 10.1111/nep.13177.

PMID:
28990729
9.

"A Mixed Blessing": Social Support as a Coping Resource for Parents Who Lost a Child in Terrorist Attacks in Israel.

Saka Y.

Omega (Westport). 2019 Dec;80(2):280-304. doi: 10.1177/0030222817732466. Epub 2017 Sep 24.

PMID:
28942706
10.

The relationship between salivary amylase and the physical and psychological changes elicited by continuation of autogenic training in patients with functional somatic syndrome.

Kiba T, Abe T, Kanbara K, Kato F, Kawashima S, Saka Y, Yamamoto K, Mizuno Y, Nishiyama J, Fukunaga M.

Biopsychosoc Med. 2017 Jun 28;11:17. doi: 10.1186/s13030-017-0103-y. eCollection 2017.

11.

Pain threshold reflects psychological traits in patients with chronic pain: a cross-sectional study.

Kato F, Abe T, Kanbara K, Ban I, Kiba T, Kawashima S, Saka Y, Mizuno Y, Fukunaga M.

Biopsychosoc Med. 2017 May 12;11:13. doi: 10.1186/s13030-017-0098-4. eCollection 2017.

12.

Quality of life of elderly patients on peritoneal dialysis versus hemodialysis: a single-center study.

Saka Y, Naruse T, Tawada N, Tokomoto M, Noda Y, Taniguchi Y, Nagahara Y, Yamashita R, Karasawa M, Watanabe Y, Ito Y.

Clin Exp Nephrol. 2017 Oct;21(5):919-925. doi: 10.1007/s10157-016-1374-5. Epub 2016 Dec 20.

PMID:
27999960
13.

Synthetic biology routes to bio-artificial intelligence.

Nesbeth DN, Zaikin A, Saka Y, Romano MC, Giuraniuc CV, Kanakov O, Laptyeva T.

Essays Biochem. 2016 Nov 30;60(4):381-391. Review.

14.

Patterns in response to chronic terrorism threats: A construct of emotional, cognitive, and behavioral responses among Israeli citizens.

Cohen-Louck K, Saka Y.

Stress Health. 2017 Oct;33(4):448-458. doi: 10.1002/smi.2728. Epub 2016 Nov 10.

PMID:
27862933
15.

Holocaust memory reconstruction among bereaved parents.

Cohen-Louck K, Saka Y.

Death Stud. 2017 Feb;41(2):93-102. doi: 10.1080/07481187.2016.1214634. Epub 2016 Aug 30.

PMID:
27572946
16.

Two-year prognosis after residential treatment for patients with alcohol dependence: three chief guidelines for sobriety in Japan.

Cho T, Negoro H, Saka Y, Morikawa M, Kishimoto T.

Neuropsychiatr Dis Treat. 2016 Aug 5;12:1983-91. doi: 10.2147/NDT.S111230. eCollection 2016.

17.

Short Synthetic Terminators for Assembly of Transcription Units in Vitro and Stable Chromosomal Integration in Yeast S. cerevisiae.

MacPherson M, Saka Y.

ACS Synth Biol. 2017 Jan 20;6(1):130-138. doi: 10.1021/acssynbio.6b00165. Epub 2016 Aug 25.

PMID:
27529501
18.

Rapidly progressive lupus nephritis associated with golimumab in a patient with systemic lupus erythematosus and rheumatoid arthritis.

Saka Y, Taniguchi Y, Nagahara Y, Yamashita R, Karasawa M, Naruse T, Watanabe Y.

Lupus. 2017 Apr;26(4):447-448. doi: 10.1177/0961203316662724. Epub 2016 Aug 20. No abstract available.

PMID:
27510604
20.

Recent analysis of status and outcomes of peritoneal dialysis in the Tokai area of Japan: the second report of the Tokai peritoneal dialysis registry.

Mizuno M, Ito Y, Suzuki Y, Sakata F, Saka Y, Hiramatsu T, Tamai H, Mizutani M, Naruse T, Ohashi N, Kasuga H, Shimizu H, Kurata H, Kurata K, Suzuki S, Kido S, Tsuruta Y, Matsuoka T, Horie M, Maruyama S, Matsuo S.

Clin Exp Nephrol. 2016 Dec;20(6):960-971. doi: 10.1007/s10157-016-1249-9. Epub 2016 Mar 7.

PMID:
26951303
21.

Antimalarial and cytotoxic properties of Chukrasia tabularis A. Juss and Turraea vogelii Hook F. Ex. Benth.

Ogbole OO, Saka YA, Fasinu PS, Fadare AA, Ajaiyeoba EO.

Parasitol Res. 2016 Apr;115(4):1667-74. doi: 10.1007/s00436-016-4906-8. Epub 2016 Feb 25.

PMID:
26911147
22.

Accurate chromosome segregation by probabilistic self-organisation.

Saka Y, Giuraniuc CV, Ohkura H.

BMC Biol. 2015 Aug 12;13:65. doi: 10.1186/s12915-015-0172-y.

23.

Saliva amylase as a measure of sympathetic change elicited by autogenic training in patients with functional somatic syndromes.

Kiba T, Kanbara K, Ban I, Kato F, Kawashima S, Saka Y, Yamamoto K, Nishiyama J, Mizuno Y, Abe T, Fukunaga M.

Appl Psychophysiol Biofeedback. 2015 Dec;40(4):339-47. doi: 10.1007/s10484-015-9303-z.

PMID:
26219656
24.

Lymphatic filariasis baseline survey in two sentinel sites of Ogun state, Nigeria.

Okorie PN, Davies E, Ogunmola OO, Ojurongbe O, Saka Y, Okoeguale B, Braide EI.

Pan Afr Med J. 2015 Apr 23;20:397. doi: 10.11604/pamj.2015.20.397.5686. eCollection 2015.

25.

Bayesian geostatistical model-based estimates of soil-transmitted helminth infection in Nigeria, including annual deworming requirements.

Oluwole AS, Ekpo UF, Karagiannis-Voules DA, Abe EM, Olamiju FO, Isiyaku S, Okoronkwo C, Saka Y, Nebe OJ, Braide EI, Mafiana CF, Utzinger J, Vounatsou P.

PLoS Negl Trop Dis. 2015 Apr 24;9(4):e0003740. doi: 10.1371/journal.pntd.0003740. eCollection 2015 Apr.

26.

Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.

Evans DS, Alphonsus K, Umaru J, Eigege A, Miri E, Mafuyai H, Gonzales-Peralta C, Adamani W, Pede E, Umbugadu C, Saka Y, Okoeguale B, Richards FO.

PLoS Negl Trop Dis. 2014 Sep 18;8(9):e3113. doi: 10.1371/journal.pntd.0003113. eCollection 2014 Sep.

27.

Efficacy and safety of fluoroscopic manipulation using the alpha-replacer for peritoneal catheter malposition.

Saka Y, Ito Y, Iida Y, Maruyama S, Matsuo S.

Clin Exp Nephrol. 2015 Jun;19(3):521-6. doi: 10.1007/s10157-014-1007-9. Epub 2014 Jul 17.

PMID:
25030751
28.

Lymphatic filariasis in Nigeria; micro-stratification overlap mapping (MOM) as a prerequisite for cost-effective resource utilization in control and surveillance.

Okorie PN, Ademowo GO, Saka Y, Davies E, Okoronkwo C, Bockarie MJ, Molyneux DH, Kelly-Hope LA.

PLoS Negl Trop Dis. 2013 Sep 5;7(9):e2416. doi: 10.1371/journal.pntd.0002416. eCollection 2013.

29.

Mapping and prediction of schistosomiasis in Nigeria using compiled survey data and Bayesian geospatial modelling.

Ekpo UF, Hürlimann E, Schur N, Oluwole AS, Abe EM, Mafe MA, Nebe OJ, Isiyaku S, Olamiju F, Kadiri M, Poopola TO, Braide EI, Saka Y, Mafiana CF, Kristensen TK, Utzinger J, Vounatsou P.

Geospat Health. 2013 May;7(2):355-66.

30.

Gateway vectors for efficient artificial gene assembly in vitro and expression in yeast Saccharomyces cerevisiae.

Giuraniuc CV, MacPherson M, Saka Y.

PLoS One. 2013 May 10;8(5):e64419. doi: 10.1371/journal.pone.0064419. Print 2013. Erratum in: PLoS One. 2016;11(2):e0150127.

31.

[Effects of alcohol reduction in patients with alcoholic liver disease].

Fujita N, Iwasa M, Cho T, Saka Y, Harada M, Takei Y.

Nihon Arukoru Yakubutsu Igakkai Zasshi. 2013 Feb;48(1):32-8. Japanese. No abstract available.

PMID:
23659003
32.

Serum-starved adipose-derived stromal cells ameliorate crescentic GN by promoting immunoregulatory macrophages.

Furuhashi K, Tsuboi N, Shimizu A, Katsuno T, Kim H, Saka Y, Ozaki T, Sado Y, Imai E, Matsuo S, Maruyama S.

J Am Soc Nephrol. 2013 Mar;24(4):587-603. doi: 10.1681/ASN.2012030264. Epub 2013 Mar 7.

33.

The efficacy of student-centered instruction in supporting science learning.

Granger EM, Bevis TH, Saka Y, Southerland SA, Sampson V, Tate RL.

Science. 2012 Oct 5;338(6103):105-8. doi: 10.1126/science.1223709.

34.

Low serum cultured adipose tissue-derived stromal cells ameliorate acute kidney injury in rats.

Katsuno T, Ozaki T, Saka Y, Furuhashi K, Kim H, Yasuda K, Yamamoto T, Sato W, Tsuboi N, Mizuno M, Ito Y, Imai E, Matsuo S, Maruyama S.

Cell Transplant. 2013;22(2):287-97. doi: 10.3727/096368912X655019. Epub 2012 Sep 7.

PMID:
22963874
35.

Mathematical modeling of gene regulatory networks in Xenopus development.

Saka Y.

Methods Mol Biol. 2012;917:497-513. doi: 10.1007/978-1-61779-992-1_28.

PMID:
22956106
36.

Autologous cell therapy for cisplatin-induced acute kidney injury by using non-expanded adipose tissue-derived cells.

Yasuda K, Ozaki T, Saka Y, Yamamoto T, Gotoh M, Ito Y, Yuzawa Y, Matsuo S, Maruyama S.

Cytotherapy. 2012 Oct;14(9):1089-100. doi: 10.3109/14653249.2012.693157. Epub 2012 Jun 25.

PMID:
22731757
37.

Aliskiren-induced chyloperitoneum in a patient on peritoneal dialysis.

Saka Y, Tachi H, Sakurai H, Tawada M, Sawai A, Shimamura Y, Mizuno M, Maruyama S, Matsuo S, Ito Y.

Perit Dial Int. 2012 Jan-Feb;32(1):111-3. doi: 10.3747/pdi.2011.00049. No abstract available.

38.

Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria.

Richards FO, Eigege A, Miri ES, Kal A, Umaru J, Pam D, Rakers LJ, Sambo Y, Danboyi J, Ibrahim B, Adelamo SE, Ogah G, Goshit D, Oyenekan OK, Mathieu E, Withers PC, Saka YA, Jiya J, Hopkins DR.

PLoS Negl Trop Dis. 2011 Oct;5(10):e1346. doi: 10.1371/journal.pntd.0001346. Epub 2011 Oct 11.

39.

Increased urethral resistance by periurethral injection of low serum cultured adipose-derived mesenchymal stromal cells in rats.

Watanabe T, Maruyama S, Yamamoto T, Kamo I, Yasuda K, Saka Y, Ozaki T, Yuzawa Y, Matsuo S, Gotoh M.

Int J Urol. 2011 Sep;18(9):659-66. doi: 10.1111/j.1442-2042.2011.02795.x. Epub 2011 Jun 26.

40.

Adipose-derived stromal cells cultured in a low-serum medium, but not bone marrow-derived stromal cells, impede xenoantibody production.

Saka Y, Furuhashi K, Katsuno T, Kim H, Ozaki T, Iwasaki K, Haneda M, Sato W, Tsuboi N, Ito Y, Matsuo S, Kobayashi T, Maruyama S.

Xenotransplantation. 2011 May-Jun;18(3):196-208. doi: 10.1111/j.1399-3089.2011.00640.x.

PMID:
21696449
41.

Theoretical basis of the community effect in development.

Saka Y, Lhoussaine C, Kuttler C, Ullner E, Thiel M.

BMC Syst Biol. 2011 Apr 17;5:54. doi: 10.1186/1752-0509-5-54.

42.

Novel culture system of mesenchymal stromal cells from human subcutaneous adipose tissue.

Iwashima S, Ozaki T, Maruyama S, Saka Y, Kobori M, Omae K, Yamaguchi H, Niimi T, Toriyama K, Kamei Y, Torii S, Murohara T, Yuzawa Y, Kitagawa Y, Matsuo S.

Stem Cells Dev. 2009 May;18(4):533-43. doi: 10.1089/scd.2008.0358.

PMID:
19055360
43.

Contrasting alteration patterns of different cartilage plates in knee articular cartilage after spinal cord injury in rats.

Moriyama H, Nishihara K, Hosoda M, Saka Y, Kanemura N, Takayanagi K, Yoshimura O, Tobimatsu Y.

Spinal Cord. 2009 Mar;47(3):218-24. doi: 10.1038/sc.2008.96. Epub 2008 Aug 5.

PMID:
18679403
44.

Visualizing protein interactions by bimolecular fluorescence complementation in Xenopus.

Saka Y, Hagemann AI, Smith JC.

Methods. 2008 Jul;45(3):192-5. doi: 10.1016/j.ymeth.2008.06.005. Epub 2008 Jun 27.

PMID:
18586100
45.

Yasushi Saka: stirring a melting pot of math and morphogens. Interviewed by Ruth Williams.

Saka Y.

J Cell Biol. 2008 Jun 2;181(5):716-7. doi: 10.1083/jcb.1815pi. No abstract available.

46.

The mRNA expression of neurotrophins in different skeletal muscles of young rats.

Saka Y, Yoshimura O, Tahara H, Takeda Y, Moriyama H, Maejima H, Tobimatsu Y.

Hiroshima J Med Sci. 2007 Dec;56(3-4):23-8.

PMID:
18516930
47.

All-optical switching in a distributed-feedback GaInAsP waveguide.

Nakatsuhara K, Mizumoto T, Takahashi E, Hossain S, Saka Y, Ma BJ, Nakano Y.

Appl Opt. 1999 Jun 20;38(18):3911-6.

PMID:
18319998
48.

Understanding how morphogens work.

Smith JC, Hagemann A, Saka Y, Williams PH.

Philos Trans R Soc Lond B Biol Sci. 2008 Apr 12;363(1495):1387-92. doi: 10.1098/rstb.2007.2256. Review.

49.

A mechanism regulating the onset of Sox2 expression in the embryonic neural plate.

Papanayotou C, Mey A, Birot AM, Saka Y, Boast S, Smith JC, Samarut J, Stern CD.

PLoS Biol. 2008 Jan;6(1):e2. doi: 10.1371/journal.pbio.0060002.

50.

Nuclear accumulation of Smad complexes occurs only after the midblastula transition in Xenopus.

Saka Y, Hagemann AI, Piepenburg O, Smith JC.

Development. 2007 Dec;134(23):4209-18. Epub 2007 Oct 24.

Supplemental Content

Support Center